Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

ARNA 1.67 -0.01 (-0.60%)
price chart
Arena Pharmaceuticals Inc Realized Volatility Hits An Inflection Point
This is a proprietary realized volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for Arena Pharmaceuticals Inc (NASDAQ:ARNA) . We examine the little used gem of daily stock volatilty over a ...
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Arena Pharmaceuticals Inc. ARNA, -5.62% shares rose 8.8% in pre-market trade Tuesday after the company said its weight-loss drug with Eisai Inc. 4523, +0.46% received Food and Drug Administration approval.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) added about 5.1 percent in value ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is expected to announce second quarter financial results estimated on August 03, 2016.
The Insider Activity Don't Lie: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)  Review Fortune
Review Analyst's saying: AbbVie Inc. (NYSE:ABBV) , Arena Pharmaceuticals ...  Is stories
Analyst's Stocks Ratings Trend: GlaxoSmithKline PLC (NYSE:GSK) , Arena ...
On 7/27/2016, shares of GlaxoSmithKline PLC (NYSE:GSK) rose +2.17% in trading session and finally closed at $45.12. The company most recent volume stood at 6.01 million shares as compared to average volume of 3.51 million shares. Over the one year ...
Eisai Inc. and Arena Pharmaceuticals Announce FDA Approval of BELVIQ XR ...
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 19, 2016 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the U.S.
Arena - Belviq Scripts Start Q3 In Tough Shape  Seeking Alpha
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock rises 8.8% after weight-loss ...  Benchmark Monitor
Company Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. and Eisai Inc ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai Inc. announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has granted regulatory approval of the chronic weight management agent VENESPRI´┐Ż(lorcaserin HCl: ...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Receives Consensus Rating of " ...  BBNS
Arena Pharmaceuticals boosted as obesity drug gets Mexican approval  Proactive Investors USA & Canada
Biotech Stocks Worth Chasing: Celgene Corp. (CELG), Arena Pharmaceuticals, Inc ...
Arena Pharmaceuticals, Inc. (ARNA) recently recorded 0.6 percent change and currently at $1.67 is 28.46 percent away from its 52-week low and down -59.95 percent versus its peak.
Arena Pharmaceuticals Inc Stock Technicals at Critical Inflection Point
This is a technical analysis stock rating for Arena Pharmaceuticals Inc (NASDAQ:ARNA) . The company has a three bull technical rating which indicates an inflection point.
Biotech stocks for your portfolio: Inovio Pharmaceuticals, Inc. (INO), Arena ...
Inovio Pharmaceuticals, Inc. (INO) ended last trading session with a change of -3.08 percent. It trades at an average volume of 1.64M shares versus 1.07M shares recorded at the end of last trading session.
Biotech Stocks Worth Chasing: Arena Pharmaceuticals, Inc. (ARNA), ZIOPHARM ...
Arena Pharmaceuticals, Inc. (ARNA) ended last trading session with a change of 2.41 percent. It trades at an average volume of 1.75M shares versus 1.84M shares recorded at the end of last trading session.